| Ms Mai Tsukikawa, MD | |
|
4650 Palm Ave, San Diego, CA 92154-8404 | |
| (844) 424-1867 | |
| Not Available |
| Full Name | Ms Mai Tsukikawa |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Location | 4650 Palm Ave, San Diego, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093249682 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 2021-01837 (North Carolina) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
Sangamo BioSciences, Inc. announced today the initiation of two new Phase 2 clinical studies (SB-728-1101 and SB-728-902, Cohort 5) in its program to develop a "functional cure" for HIV/AIDS.
This year's recipients of the most important prize for early career researchers in Germany have been announced. The selection committee, appointed by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) and the German Federal Ministry of Education and Research (BMBF), has chosen ten researchers, five women and five men, to receive the 2015 Heinz Maier-Leibnitz Prizes.
Cancer remains one of the most difficult and deadly challenges in human health, affecting Kentuckians at a higher rate than residents of any other state and killing more than 600,000 people each year in the U.S. alone.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded contracts to three organizations to support early-stage human clinical trials of investigational infectious disease treatments. The new awards for the Phase I Clinical Trial Units for Therapeutics increases the number of funded organizations under the program from two to three, expanding capacity for conducting early safety testing of novel investigational drugs.
Although one may think of psychedelic pharmaceuticals as being dangerous and detrimental, scientists have been conducting experiments and clinical trials on some of them and have obtained positive results when testing them for medical use.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Mai Tsukikawa, MD 7037 Everglades Ave, San Diego, CA 92119-2307 Ph: (808) 542-3890 | Ms Mai Tsukikawa, MD 4650 Palm Ave, San Diego, CA 92154-8404 Ph: (844) 424-1867 |
News Archive
Sangamo BioSciences, Inc. announced today the initiation of two new Phase 2 clinical studies (SB-728-1101 and SB-728-902, Cohort 5) in its program to develop a "functional cure" for HIV/AIDS.
This year's recipients of the most important prize for early career researchers in Germany have been announced. The selection committee, appointed by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) and the German Federal Ministry of Education and Research (BMBF), has chosen ten researchers, five women and five men, to receive the 2015 Heinz Maier-Leibnitz Prizes.
Cancer remains one of the most difficult and deadly challenges in human health, affecting Kentuckians at a higher rate than residents of any other state and killing more than 600,000 people each year in the U.S. alone.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded contracts to three organizations to support early-stage human clinical trials of investigational infectious disease treatments. The new awards for the Phase I Clinical Trial Units for Therapeutics increases the number of funded organizations under the program from two to three, expanding capacity for conducting early safety testing of novel investigational drugs.
Although one may think of psychedelic pharmaceuticals as being dangerous and detrimental, scientists have been conducting experiments and clinical trials on some of them and have obtained positive results when testing them for medical use.
› Verified 3 days ago
Dr. Kirsta Lynn Brummel, DO Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 16776 Bernardo Center Dr Ste 203, San Diego, CA 92128 Phone: 619-929-0818 | |
Kent Alan Blade, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 34800 Bob Wilson Dr, San Diego, CA 92134 Phone: 619-532-6702 Fax: 619-532-7272 | |
Dr. Chirag M Shah, M.D., MPH Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 16766 Bernardo Center Dr, San Diego, CA 92128 Phone: 858-381-0686 Fax: 858-365-5189 | |
Ellie E Samadani, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3737 Moraga Ave, Suite A105, San Diego, CA 92117 Phone: 858-273-0200 Fax: 858-273-0619 | |
Dr. Brittany Elizabeth Powell, Ophthalmology Medicare: Medicare Enrolled Practice Location: 34800 Bob Wilson Dr, San Diego, CA 92134 Phone: 619-632-6700 | |
Frank Fonted Tsai, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3075 Health Center Dr Ste 401, San Diego, CA 92123 Phone: 589-395-4058 | |
Anjali Sheena Parekh, M.D Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 16899 W Bernardo Dr, San Diego, CA 92127 Phone: 858-521-2301 |